annual CFF:
$12.27M+$10.77M(+720.47%)Summary
- As of today (May 29, 2025), KNSA annual cash flow from financing activities is $12.27 million, with the most recent change of +$10.77 million (+720.47%) on December 31, 2024.
- During the last 3 years, KNSA annual CFF has risen by +$6.38 million (+108.43%).
- KNSA annual CFF is now -96.46% below its all-time high of $346.74 million, reached on December 31, 2018.
Performance
KNSA Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$2.77M+$626.00K(+29.23%)Summary
- As of today (May 29, 2025), KNSA quarterly cash flow from financing activities is $2.77 million, with the most recent change of +$626.00 thousand (+29.23%) on March 31, 2025.
- Over the past year, KNSA quarterly CFF has dropped by -$845.00 thousand (-23.39%).
- KNSA quarterly CFF is now -98.55% below its all-time high of $190.81 million, reached on March 31, 2018.
Performance
KNSA quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$11.42M-$845.00K(-6.89%)Summary
- As of today (May 29, 2025), KNSA TTM cash flow from financing activities is $11.42 million, with the most recent change of -$845.00 thousand (-6.89%) on March 31, 2025.
- Over the past year, KNSA TTM CFF has increased by +$6.40 million (+127.60%).
- KNSA TTM CFF is now -96.71% below its all-time high of $347.21 million, reached on June 30, 2018.
Performance
KNSA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
KNSA Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +720.5% | -23.4% | +127.6% |
| 3 y3 years | +108.4% | +554.4% | +119.5% |
| 5 y5 years | -85.4% | +14.7% | +242.6% |
KNSA Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +720.5% | -58.6% | +1655.1% | -6.9% | +664.0% |
| 5 y | 5-year | -94.6% | +720.5% | -98.1% | +1655.1% | -95.0% | +664.0% |
| alltime | all time | -96.5% | +720.5% | -98.5% | +463.3% | -96.7% | +664.0% |
KNSA Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $2.77M(+29.2%) | $11.42M(-6.9%) |
| Dec 2024 | $12.27M(+720.5%) | $2.14M(-68.0%) | $12.27M(+13.4%) |
| Sep 2024 | - | $6.69M(-3857.9%) | $10.82M(+131.1%) |
| Jun 2024 | - | -$178.00K(-104.9%) | $4.68M(-6.7%) |
| Mar 2024 | - | $3.61M(+419.9%) | $5.02M(+235.7%) |
| Dec 2023 | $1.50M(-40.6%) | $695.00K(+25.9%) | $1.50M(-24.9%) |
| Sep 2023 | - | $552.00K(+249.4%) | $1.99M(+10.6%) |
| Jun 2023 | - | $158.00K(+75.6%) | $1.80M(-17.6%) |
| Mar 2023 | - | $90.00K(-92.4%) | $2.18M(-13.2%) |
| Dec 2022 | $2.52M(-57.2%) | $1.19M(+229.6%) | $2.52M(-0.9%) |
| Sep 2022 | - | $361.00K(-33.4%) | $2.54M(-47.7%) |
| Jun 2022 | - | $542.00K(+28.1%) | $4.86M(-6.6%) |
| Mar 2022 | - | $423.00K(-65.1%) | $5.20M(-11.6%) |
| Dec 2021 | $5.88M(-97.4%) | $1.21M(-54.8%) | $5.88M(+9.3%) |
| Sep 2021 | - | $2.68M(+202.1%) | $5.38M(-96.4%) |
| Jun 2021 | - | $887.00K(-19.8%) | $149.10M(-34.0%) |
| Mar 2021 | - | $1.11M(+55.3%) | $225.78M(-0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $227.09M(+170.0%) | $712.00K(-99.5%) | $227.09M(+0.1%) |
| Sep 2020 | - | $146.40M(+88.8%) | $226.75M(+182.0%) |
| Jun 2020 | - | $77.56M(+3113.0%) | $80.40M(+2311.5%) |
| Mar 2020 | - | $2.41M(+547.2%) | $3.33M(-96.0%) |
| Dec 2019 | $84.11M(-75.7%) | $373.00K(+603.8%) | $84.11M(+0.1%) |
| Sep 2019 | - | $53.00K(-89.3%) | $84.03M(+1.0%) |
| Jun 2019 | - | $494.00K(-99.4%) | $83.21M(-65.2%) |
| Mar 2019 | - | $83.19M(>+9900.0%) | $239.11M(-31.0%) |
| Dec 2018 | $346.74M(+769.6%) | $291.00K(-138.2%) | $346.74M(+0.1%) |
| Sep 2018 | - | -$762.00K(-100.5%) | $346.44M(-0.2%) |
| Jun 2018 | - | $156.40M(-18.0%) | $347.21M(+82.0%) |
| Mar 2018 | - | $190.81M(>+9900.0%) | $190.81M(+378.5%) |
| Dec 2017 | $39.87M(-6.2%) | $0.00(0.0%) | $39.87M(0.0%) |
| Sep 2017 | - | $0.00(0.0%) | $39.87M(0.0%) |
| Jun 2017 | - | $0.00(-100.0%) | $39.87M(0.0%) |
| Mar 2017 | - | $39.87M | $39.87M |
| Dec 2016 | $42.51M | - | - |
FAQ
- What is Kiniksa Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual CFF year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly CFF year-on-year change?
- What is Kiniksa Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals TTM CFF year-on-year change?
What is Kiniksa Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of KNSA is $12.27M
What is the all time high annual CFF for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual cash flow from financing activities is $346.74M
What is Kiniksa Pharmaceuticals annual CFF year-on-year change?
Over the past year, KNSA annual cash flow from financing activities has changed by +$10.77M (+720.47%)
What is Kiniksa Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of KNSA is $2.77M
What is the all time high quarterly CFF for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly cash flow from financing activities is $190.81M
What is Kiniksa Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, KNSA quarterly cash flow from financing activities has changed by -$845.00K (-23.39%)
What is Kiniksa Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of KNSA is $11.42M
What is the all time high TTM CFF for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high TTM cash flow from financing activities is $347.21M
What is Kiniksa Pharmaceuticals TTM CFF year-on-year change?
Over the past year, KNSA TTM cash flow from financing activities has changed by +$6.40M (+127.60%)